Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)

Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure

NCT07117409 ·Status: TERMINATED

An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma

NCT02596035 ·Status: COMPLETED ·Phase: PHASE4

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

NCT00351949 ·Status: COMPLETED ·Phase: PHASE1

Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma

NCT06934057 ·Status: RECRUITING ·Phase: PHASE4

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

NCT03647878 ·Status: ACTIVE_NOT_RECRUITING

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

NCT04416646 ·Status: COMPLETED

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

NCT05501054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

NCT06399419 ·Status: RECRUITING ·Phase: PHASE1

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

NCT00830895 ·Status: COMPLETED ·Phase: PHASE2

A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

NCT04088500 ·Status: TERMINATED ·Phase: PHASE2

Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

NCT03419572 ·Status: COMPLETED

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

NCT01444807 ·Status: UNKNOWN ·Phase: PHASE2

Participant Reported Outcomes and Treatment Experiences in Kidney Cancer

NCT04472663 ·Status: COMPLETED

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

NCT02231749 ·Status: COMPLETED ·Phase: PHASE3

A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer

NCT02960906 ·Status: COMPLETED ·Phase: PHASE2

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

NCT01668784 ·Status: COMPLETED ·Phase: PHASE3

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

NCT03075423 ·Status: COMPLETED ·Phase: PHASE2

Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer

NCT03455452 ·Status: ACTIVE_NOT_RECRUITING

Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants

NCT03568435 ·Status: COMPLETED

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

NCT04375150 ·Status: COMPLETED

A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

NCT03873402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

NCT03699579 ·Status: COMPLETED

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

NCT02848768 ·Status: COMPLETED

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

NCT03161145 ·Status: COMPLETED

A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer

NCT02982954 ·Status: COMPLETED ·Phase: PHASE4